Advertisement

Covishield triggers more antibodies than Covaxin: Study

11:55 PM Jun 06, 2021 | FPJ Bureau

NEW DELHI: A latest study suggests Covishield triggers more antibodies than Covaxin; as part of this study, doctors and nurses received both doses of either of the two Covid-19 vaccines.

The study conducted by Dr AK Singh and his colleagues states that both vaccines elicited a good immune response. Unpublished data had earlier indicated that Covishield was found to be 70 per cent effective after the first dose. At the same time, preliminary data from its phase 3 trial put Covaxin's efficacy rate at 81 per cent.

Advertisement
Advertisement

So, while both elicited a good immune response after two doses, seropositivity rates and median anti-spike antibody titre was significantly higher in Covishield as compared to that in Covaxin.

Advertisement

Both vaccine recipients had similar solicited mild to moderate adverse events and none had severe or unsolicited side effects.

COVID-19: Delta variant is 40% more transmissible, says UK minister

(To receive our E-paper on whatsapp daily, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

(To view our epaper please Read Now. For all the latest News, Mumbai, Entertainment, Cricket, Business and Featured News updates, visit Free Press Journal. Also, follow us on Twitter and Instagram and do like our Facebook page for continuous updates on the go)

Advertisement